TREM2 and early-onset autosomal dominant Alzheimer disease: Interestingly, the transcriptomic approach on ex vivo brain tissue from a murine model of Alzheimer’s disease recently led to characterization of a novel phenotype of activated microglia, distinct from Trem2-ApoE-Clec7a-expressing DAM, but still increasing (as DAM) along disease progression.